Keyword
Quick search:
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 The CLEAR Study in mRCC
2 PD-1 Vs PD-L1 Inhibition for Frontline mRCC
3 Monroe Capital (MRCC) Surpasses Q1 Earnings Estimates
4 Using TKI/IO Combinations in Patients With mRCC
5 Monroe Capital Corp (MRCC) falls 1.14% for May 11
6 The CheckMate 9ER Study in mRCC
7 Promising Studies for the Future of Frontline mRCC
8 Purdue will be new home for Midwestern Regional Climate Center
9 Frontline Treatment for Intermediate/Poor-Risk mRCC
10 Monroe Capital Corp (MRCC) CEO Theodore Koenig on Q1 2021 Results
11 Novel Strategies for Intermediate-/Poor-Risk mRCC: Optimizing Therapy
12 Favorable-Risk mRCC: Aggressive Therapy and Disease Progression
13 Lenvatinib-Based Combinations for Intermediate-/Poor-Risk mRCC
14 Purdue New Home for Climate Center
15 Occult Brain Mets Detected in Patients With Advanced Renal Cancer
16 Active Surveillance Deemed “Justifiable” Option for Metastatic Renal Cell Carcinoma
17 Higher BMI May Be Associated With Improved Overall Survival in Patients with Metastatic Kidney Cancer
18 MRCC and Specialist Hospital (MRCC) Opens World-Class Cancer Treatment Facility in Lagos
19 Yet another Frost Advisory after tonight's light rain chance
20 Monroe Capital: Q1 Earnings Snapshot
21 Monroe Capital Corporation BDC Announces First Quarter 2021
22 Marcelle Ruth Cancer Centre Specialist Hospital (MRCC) opens doors in Lagos, bringing world-class cancer treatment to Nigeria and Sub-Saharan Africa
23 Marcelle Ruth Cancer Centre and Specialist Hospital Inaugurated in Lagos
24 Study supports routine brain imaging at baseline in metastatic kidney cancer
25 Cyclone Tauktae: Efforts on to alert Tamil Nadu fishermen
26 Indian Coast Guard locates missing fishing boat Mercedes at high seas
27 Update: Adjustments made to operations at three courts
28 Monroe Capital Corporation Schedules First Quarter 2021 Earnings Release and Conference Call
29 Sapanisertib: Poor Activity, More AEs in mRCC
30 Redistricting commission to launch first of 16 public hearings Tuesday in Jackson
31 Monroe Capital: Q1 Earnings Insights
32 ICG brings missing fishing boat to home port in Tamil Nadu's Thengapattanam, all 11 crew members safe
33 High BMI Levels Associated With Improved Overall Survival for Patients with mRCC Treated with ICIs
34 Frontline mRCC Paradigm Crowds Among Immune-Based Treatment Options
35 Treatment Advances for Frontline mRCC
36 How to participate in Michigan redistricting commission hearings
37 MERECA Trial Meets OS Endpoint with Ilixadencel/Sunitinib in mRCC
38 Axitinib Yields Better Tumor Response Rate Over Nivolumab in mRCC
39 Ilixadencel/Sunitinib Combo Showcases Promising Survival Benefit in mRCC
40 Monroe Capital Corporation BDC Announces Third Quarter 2020 Results
41 ASCO GU 2021: Real-World Treatment Patterns and Sequencing for mRCC: Results from the Flatiron Database
42 Michigan Redistricting Commission now taking public comment, map suggestions
43 14 crew members of cargo ship from India test positive for Covid in South Africa
44 Giving Rural Missouri a Voice
45 Radical nephrectomy before or after systemic therapy for mRCC
46 Favorable-Risk mRCC: Sequencing Therapy
47 Phase 2 MERECA Trial Continues to Show Promise for Ilixadencel-Sunitinib Combination for mRCC
48 CheckMate-9ER Sets the Bar for Research With Triplets, Response-Guided Therapy in mRCC
49 Complete Metastasectomy Found to Prolong Survival in mRCC
50 Frontline Therapy for mRCC: Is Two Better Than One?
51 Analysis suggests survival improved when cytoreductive nephrectomy added to immunotherapy in mRCC
52 Survival in mRCC Varies By Histologic Subtype, Metastasis Site
53 Cytoreductive Nephrectomy, Immunotherapy-Based Systemic Therapy Induce Benefit in mRCC
54 Ashfield Capital Partners, LLC Buys Teradyne Inc, Alibaba Group Holding, The Estee Lauder Inc, Sells eHealth
55 EAU 2020: Immunotherapy Combinations for Intermediate-Poor Risk mRCC: IO + IO
56 Advanced Renal Cell Carcinoma Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis By Delveinsight
57 Monroe Capital Corporation (MRCC) Ex-Dividend Date Scheduled for March 15, 2021
58 Frontline Ilixadencel Plus Sunitinib Demonstrates Further Survival Benefit in mRCC
59 Financial Sector Update for 03/03/2021: UWMC, MKTX, MRCC, XLF, FAS, FAZ
60 An Illustrative Case of Combination Cabozantinib/Nivolumab for Progressive Metastatic Renal Cell Carcinoma (mRCC)
61 The PDIGREE Trial
62 Real-World Data: Cabozantinib Used More Commonly Than Other TKIs After Checkpoint Inhibition in mRCC
63 Sequential Nivolumab and Ipilimumab Regimen Does Not Show Benefit in mRCC
64 NLR Rise May Predict Mortality, Treatment Failure Risks in mRCC
65 Monroe Capital
66 Pembrolizumab for first-line mRCC: Anecdotal evidence in real-world setting
67 Young bald eagle found near death recovering at raptor center
68 Congress picks Marathi face to head MRCC but does a balancing act
69 Monroe Capital (MRCC) Q1 2020 Earnings Call Transcript
70 Monroe Capital Corporation Closes Offering of $130 Million 4.75% Notes Due 2026
71 Monroe Capital Corporation Prices Offering of $130 Million 4.75% Notes Due 2026
72 Siddhesh Wath scores unbeaten 145 to guide MRCC to title triumph
73 ASCO GU 2021: Outcomes of First-Line Immuno-Oncology Combination Therapies in Metastatic Renal Cell Carcinoma: Results from the International mRCC Database Consortium
74 Tivozanib Offers Survival Benefit Similar to Sorafenib in Refractory mRCC
75 Immune Checkpoint Inhibitor Combinations Play Important Role in mRCC
76 Here is What Hedge Funds Think About Monroe Capital Corp (MRCC)
77 11.6% Yield, Low Leverage, Why Monroe Capital May Be A Good Bet
78 Time on mRCC Drug Linked to Survival
79 James Craig's possible run thrills Michigan GOP. Detroiters, not so much.
80 Monroe Capital Corp: Rising Share Price & Safe 10% Dividend
81 A Combination of Potential Biomarkers May Help Predict Response to Immunotherapy in mRCC
82 Monroe Capital Corporation Schedules Third Quarter 2020 Earnings Release and Conference Call
83 Ipilimumab Plus Nivolumab Effective for mRCC With Brain Metastases
84 MRCC recognized among the top 25 businesses that emerged as frontrunners in the last 25 years
85 Monmouth Regional Chamber Seeks Nominees for 2021 Athena Leadership Awards
86 Japan pledges USD 3.7 million for UNODC collaboration to support MRCC
87 Post-IO Lenvima-Keytruda Combo Highly Active in mRCC
88 EP. 5: Role of Cytoreductive Nephrectomy in mRCC
89 ESMO Virtual Congress 2020: Assessment of Circulating Cell-Free Tumor DNA in 847 Patients with metastatic renal cell carcinoma (mRCC) and concordance with tissue-based testing
90 Revealed: 2,000 refugee deaths linked to illegal EU pushbacks
91 Nivolumab/Cabozantinib Prolongs OS in Advanced RCC With Sarcomatoid Features
92 MERECA Study Update Reveals Survival Benefit With Ilixadencel/Sunitinib in mRCC
93 Updates in Relapsed/Refractory Metastatic Renal Cell Carcinoma
94 ESMO Virtual Congress 2020: A Phase II Study of Patients with Advanced or Metastatic Renal Cell Carcinoma (mRCC) Receiving Pazopanib After Previous Checkpoint Inhibitor Treatment
95 TKI/Immunotherapy Combos Lead Advances in mRCC, But Questions Remain
96 Weighing Options for the Frontline Treatment of Metastatic Renal Cell Carcinoma
97 Monroe Capital Corporation Announces Third Quarter Distribution of $0.25 Per Share
98 Amazon Chooses Marion Regional Career Center
99 Dr. Lee on Treatment Options mRCC
100 Monroe Capital Corporation BDC Announces Fourth Quarter And Full Year 2020 Results